← Back to Vaccine Database

AdimrSC-2f (recombinant RBD +/- Aluminium)

Protein based vaccine · VDDBV0064

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT05104489 Phase 1COVID-19
NCT04522089 Phase 2COVID-19